UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 26, 2021
Accession Number:
0001193125-21-014799
Submission Type:
POS AM
CIK:
0001714798
Company Name:
Prevail Therapeutics Inc.
File Number:
333-239612